← Leaderboards
Colin Ashton Flaveny
Saint Louis University
$574,943
Attributed
$574,943
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $212.5K · FY2017–20$250K$187.5K$125K$62.5K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$574,943 · 2
By mechanism
R21$574,943 · 2
Top collaborators
No co-investigators on record.
Most similar at Saint Louis University
Same institution · by research overlap
- Kristine Griffett$884,550
- Ajay K. Jain$3,663,204
- Ian Mitchelle Sayo De Vera$177,066
Others in their field
Other Emerging Leaders on “Metastatic Prostate Cancer”
- Aaron Matthew Lebeau · University Of Wisconsin-Madison$5,223,811
- Joseph Grudzinski · Voximetry, Inc.$4,969,457
- Moran Amit · University Of Tx Md Anderson Can Ctr$4,827,924
- Rahul Aggarwal · University Of California, San Francisco$4,652,956
- Daniel Lyndon Jaffe Thorek · Johns Hopkins University$4,403,846
- Jeremy Goecks · Johns Hopkins University$4,197,701
Research focus
Metastatic Prostate CancerProstate Cancer CellLigandsMetabolic PathwayPathway InteractionsProstateDesignInhibitor/AntagonistLipidsMetabolicNeoplasm MetastasisNeoplastic CellPharmaceutical PreparationsProductionCastration Resistant Prostate CancerCessation Of LifeEtiologyImmune EvasionLinkLipid BiosynthesisLiver X ReceptorMalignant Neoplasm Of ProstateAgonistReceptor Signaling
Grant awards (3)
Targeting Liver-X-Receptor Regulation of Prostate Cancer Immune-Evasion$212,479
R21 · FY2020 · CA · contact PI
Treating prostate cancer by pharmacological coinhibition of the Warburg effect and lipogenesis$164,756
R21 · FY2018 · CA · contact PI
Treating prostate cancer by pharmacological coinhibition of the Warburg effect and lipogenesis$197,708
R21 · FY2017 · CA · contact PI